| certoparin versus control | |||
| Kock, 1995 | Certoparin 3000 IU versus no prophylaxis | patients with minor injuries treated with plaster-cast immobilisation of the leg | open Follow-up duration: 15 days |
| dalteparin versus placebo | |||
| D-KAf (Selby), 2007 NCT00187408 | dalteparin 5000U daily versus placebo | below-knee fractures repaired surgically | |
| Lapidus, 2007 | Dalteparin 5000 IU versus Placebo | patients surgically treated for Achilles tendon rupture | double-blind Follow-up duration: 43 days |
| Lapidus, 2007 | Dalteparin 5000 IU versus Placebo | patients undergoing ankle fracture surgery | double-blind Follow-up duration: 44 days |
| nadroparin versus control | |||
| Kujath, 1993 | Nadroparin 2850 IU versus no prophylaxis | patients with injuries of the lower limb immobilized by a plaster cast | open Follow-up duration: 16 days |
| reviparin versus placebo | |||
| Lassen, 2002 | Reviparin 1750 IU versus Placebo | patients who required immobilization in a plaster cast or brace for at least five weeks after a leg fracture or rupture of the Achilles tendon | double-blind Follow-up duration: 43 days |
| tinzaparin versus control | |||
| Jorgensen, 2002 | Tinzaparin 3500 IU versus no prophylaxis | patients over 18 years of age with planned plaster cast on a lower extremity of at least 3 weeks | open, assessor-blinded Follow-up duration: 38 days |
in first
in second
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
